Search results
Opinion | Another Lina Khan Theory Loses in Court
The Wall Street Journal· 5 hours agoFederal Trade Commission Chair Lina Khan is a heroine to the media, but not to federal judges, who keep ruling against her antitrust cases. The FTC sued...
FTC chair defends antitrust probes, noncompete rule to Congress
Modern Healthcare· 9 hours agoFederal Trade Commission Chair Lina Khan pointed to her agency's antitrust work Wednesday, including blocking healthcare mergers and investigating vertical ...
FTC Chair Lina Khan Should Take Jim Cramer's 'Unhinged' Obsession as 'Badge of Honor' | Common...
CommonDreams.org· 1 day agoA spokesperson for the American Economic Liberties Project called the CNBC host a "mouthpiece and...
WSJ Future of Everything Festival Features Interviews With Ray Dalio, Lina Khan, Awkwafina
The Wall Street Journal· 2 days agoThe Wall Street Journal’s Future of Everything Festival opens on May 21, featuring top innovators,...
Wake Up Call: Crusading FTC Chair Lina Khan a ‘Wonky Cult Hero’
Bloomberg Law· 16 hours agoWelcome to Bloomberg Law’s Wake Up Call, a daily rundown of the top news for lawyers, law firms, and in-house counsel.
How to get around the FTC’s non-compete ban
The Hill· 3 days agoIt’s funny to me what regulations catch the attention of the small- and mid-sized business owners who are my clients. Others are familiar with another...
Opinion | The education of Lina Khan, whose superpower is busting monopolies
Washington Post· 2 days agoLeading the “hipsters” of antitrust law, Khan is recovering from a rough start at the FTC.
Correction
The Wall Street Journal· 6 days agoNew York magazine quoted a former Federal Trade Commission official who said that Lina Khan “came in with a bunch of answers . . . but no actual...
Opinion | The FTC Smears Scott Sheffield
The Wall Street Journal· 6 days agoLina Khan’s agency trashes an oil executive on dubious evidence.
FTC targets 300 Big Pharma 'junk patents,' sends warning letters to top drugmakers
BenefitsPRO· 13 hours ago"By filing bogus patent listings, pharma companies block competition and inflate the cost of...